Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC44880 SD 1029

    JAK2 Inhibitor III, Janus-Associated Kinase 2 Inhibitor III

    A JAK2 inhibitor
  3. GC44839 Ridaifen-B An analog of tamoxifen
  4. GC44826 Rhapontin

    土大黄苷; Rhaponiticin

    A stilbenoid glycoside
  5. GC44820 Resveratrol-3-O-Sulfate (sodium salt) An active metabolite of resveratrol
  6. GC44813 Resistoflavine A cytotoxic Streptomyces metabolite
  7. GC44786 Pyridoxatin A fungal metabolite with diverse biological activities
  8. GC44730 proTAME

    Pro-N-4-tosyl-L-arginine methyl ester

    A prodrug form of TAME
  9. GC44707 Prostaglandin D2 Ethanolamide

    PGD2EA, Prostamide D2

    An endogenous anandamide metabolite
  10. GC44689 Procyanidin C1

    原花青素 C1; PCC1

    原花青素C1是一种多酚类化合物,存在于多种蔬菜和水果中,具有广泛的生物活性,包括抗氧化和抗炎抗癌作用 /p>\n原花青素 C 是一种从肉桂皮层纯化的儿茶素三聚体,它对 TGF-β 诱导的 EMT 显示出抑制活性。
  11. GC44652 PK7242 (maleate) An inducer of reactivation of mutant p53
  12. GC44640 Phytosphingosine

    植物鞘氨醇

    A sphingolipid
  13. GC44633 Phosphatidylserines (bovine)

    PtdSers (bovine)

    A glycerophospholipid
  14. GC44616 PGPC

    1-Palmitoyl-2-glutaryl phosphatidylcholine

    An oxidized phospholipid
  15. GC44615 PGP-4008 A selective P-glycoprotein inhibitor
  16. GC44603 Petromurin C A fungal metabolite
  17. GC44600 Periplocin

    杠柳毒苷

    A cardiac glycoside
  18. GC44587 PDMP (hydrochloride)

    DL-erythro/threo-PDMP

    An inhibitor of sphingolipid biosynthesis
  19. GC44584 PD 168368 An antagonist of NMB receptors
  20. GC44528 p,p'-DDT

    4,4'-DDT, 4,4'-Dichlorodiphenyltrichloroethane, p,p'-Dichlorodiphenyltrichloroethane, Dicophaner, NSC 8939

    p,p'-DDT is an organochlorine pesticide that induces 94.2% mortality of malaria mosquito (A.
  21. GC44453 Nornidulin

    降巢麴菌素

    A depsidone with antibacterial activity
  22. GC44409 Nivalenol

    雪腐镰刀菌烯醇

    A trichothecene mycotoxin
  23. GC44402 Nidulin

    巢曲菌素

    A depsidone
  24. GC44388 NF-κB Control

    SN50M

    A negative control peptide used with NF-κB inhibitor
  25. GC44363 Neoaureothin

    NSC 260179, Spectinabilin

    A bacterial metabolite
  26. GC44361 Nemadipine A An L-type calcium channel blocker
  27. GC44263 Myrtillin

    氯化飞燕草素葡萄糖苷; Delphinidin 3-O-glucoside chloride; Delphinidin 3-O-β-glucoside chloride

    桃金娘苷(Delphinidin 3-o-glucoside)是一种花青素单体,主要分布于各种植物中,可用高效液相色谱法(HPLC)质谱法(Mass)和核磁共振法进行定性和定量分析(NMR)。

  28. GC44260 Myristoyl Coenzyme A (hydrate)

    Myristoyl-CoA, Tetradecanoyl Coenzyme A, Tetradecanoyl-CoA

    A substrate for N-myristoyltransferase

  29. GC44251 MTIC

    替莫唑胺代谢物- MTIC

    A DNA alkylating agent
  30. GC44243 Monohydroxy Melphalan (hydrochloride)

    Hydroxymelphalan

    A DNA alkylating agent
  31. GC44227 MM-206 A STAT3 inhibitor
  32. GC44135 Mca-VDQMDGW-K(Dnp)-NH2 (ammonium salt)

    Caspase-3 Fluorogenic Substrate V

    A caspase-3 fluorogenic substrate
  33. GC44097 LY303511 (hydrochloride) An inhibitor of cell proliferation
  34. GC44096 LY293111

    Etalocib; VML 295

    A LTB4 receptor antagonist
  35. GC44087 L-threo-PPMP (hydrochloride)

    L-threo-1-phenyl-2-Palmitoylamino-3-morpholino-1-propanol

    An inhibitor of glucosylceramide synthetase
  36. GC44085 L-Sulforaphene

    莱菔素

    A natural isothiocyanate
  37. GC44080 LLP-3 Induces apoptosis by blocking Survivin/Ran interactions
  38. GC44006 Kinsenoside

    金线莲苷

    A glycoside with diverse biological activities
  39. GC44002 Kibdelone C

    (+)-Kibdelone C

    A heterocyclic polyketide
  40. GC43995 Kazusamycin B

    CL 1957E, Hydroxyleptomycin A, PD 124895

    A bacterial metabolite
  41. GC43922 Isovaleryl-L-carnitine (chloride)

    L-异戊酰基肉碱

    An acylcarnitine
  42. GC43894 IKK2 Inhibitor VI

    5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide

    An inhibitor of IKK2
  43. GC43816 Heptelidic Acid

    萜烯七脂酸; Koningic acid

    A selective, irreversible GAPDH inhibitor
  44. GC43776 Glycochenodeoxycholic Acid (sodium salt)

    甘氨鹅脱氧胆酸钠; Chenodeoxycholylglycine sodium salt; Sodium glycochenodeoxycholate

    A primary bile acid
  45. GC43762 GLP-1 (7-36) amide (trifluoroacetate salt)

    Glucagon-like Peptide 1 (7-36) amide

    A GLP-1R agonist
  46. GC43742 Gemcitabine-13C,15N2 (hydrochloride) An internal standard for the quantification of gemcitabine
  47. GC43732 Ganglioside GM3 Mixture (sodium salt)

    单唾液神经节苷酯GM3; Hematoside; Sialosyllactosylceramide

    A mixture of ganglioside GM3
  48. GC43729 Ganglioside GD3 Mixture (sodium salt)

    双唾液酸神经节苷脂GD3; Disialosyllactosylceramide

    A mixture of ganglioside GD3
  49. GC43723 Galactosylsphingosine (d18:1)

    神经鞘氨醇半乳糖苷,Galactosylsphingosine

    A bioactive sphingolipid
  50. GC43689 Fluphenazine-N-2-chloroethane (hydrochloride)

    Fluphenazine-N-mustard, FNM, FPCE, SKF-7171A

    A nitrogen mustard derivative of fluphenazine
  51. GC43668 FITC-C6-YVADAP-K(Dnp) (trifluoroacetate salt)

    FITC-C6-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH

    A caspase-1 fluorogenic substrate

Items 1451 to 1500 of 2733 total

per page

Set Descending Direction